Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential.

Jin J, Yi Z, Wang H, Gong L, Zhang Y, Xie W

Open source

DOI
10.3390/genes17080909
Published
2026 Jul 31
Container
Genes
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/genes17080909,
  title = {Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential.},
  author = {Jin J and Yi Z and Wang H and Gong L and Zhang Y and Xie W},
  year = {2026},
  journal = {Genes},
  doi = {10.3390/genes17080909},
  url = {https://doi.org/10.3390/genes17080909}
}

RIS

TY  - JOUR
TI  - Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential.
AU  - Jin J
AU  - Yi Z
AU  - Wang H
AU  - Gong L
AU  - Zhang Y
AU  - Xie W
PY  - 2026
JO  - Genes
DO  - 10.3390/genes17080909
UR  - https://doi.org/10.3390/genes17080909
ER  - 

APA

J, J., Z, Y., H, W., L, G., Y, Z., & W, X. (2026). Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential.. Genes. https://doi.org/10.3390/genes17080909

Source records